Harrison.ai

Transforming Global Healthcare Through AI

A mission-led company using artificial intelligence to scale the impact of clinicians.

Harrison.ai is one of Australia’s most ambitious HealthTech startups, built around a simple but powerful idea: the world needs more healthcare capacity, and AI can help deliver it.

Founded in 2018 by brothers Dr Aengus Tran and Dimitry Tran, the company takes a clinician-first approach to building AI tools that improve diagnostic accuracy, scale clinical care, and save lives.

With a growing global presence and technology already used in over 1,000 hospitals, Harrison.ai is helping to relieve critical pressure on health systems by working in partnership with clinicians, not replacing them.

Why Join Harrison.ai? Work with purpose, at the intersection of cutting-edge AI and patient care

Mission with impact The company’s north star is to make high-quality care as accessible as water. Every product you help build contributes to solving real-world challenges in radiology, pathology, and beyond.

Backed to scale globally With over $240 million raised and support from partners like Sonic Healthcare, Horizons Ventures, and Aware Super, Harrison.ai is expanding across the United States, Europe, and Asia-Pacific. You will be joining a well-funded team that is ready to grow.

Innovation with integrity You will work on AI products that are rigorously tested, clinically validated, and designed with patients and clinicians in mind. From FDA clearance to Breakthrough Device status, the bar is high and so is the impact.

Exceptional people and product culture Founded by a doctor and built by a team of engineers, researchers, and healthcare experts, Harrison.ai is structured for deep collaboration. Whether you are joining Franklin.ai in pathology or Annalise.ai in radiology, you will work alongside teams solving complex problems that matter.

Key Milestones

• 2018: Founded in Sydney by Aengus and Dimitry Tran
• 2020–2022: Annalise.ai and Franklin.ai launched to tackle radiology and pathology diagnostics
• 2023: Annalise’s platform used across more than 1,000 hospitals worldwide
• 2025: Raised $112 million in Series C funding to accelerate US and global expansion

12 FDA-cleared algorithms and growing

What’s Next With the recent release of Harrison.rad.1, a radiology-specific large language model, and expanding commercial deployments across North America and Europe, the company is entering a new phase of product development and international growth.

Whether your background is in medicine, engineering, or product design, Harrison.ai offers a rare chance to work on frontier technology with real-world significance.

If you want to build a career that matters, this is a company where your work could help millions.